Samenstelling L&G Pharma Breakthrough UCITS ETF - USD

ETF

BIOT

IE00BF0H7608

Beurs gesloten - Swiss Exchange 17:35:29 01-07-2024 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8,876 CHF +0,52% Intraday-grafiek van L&G Pharma Breakthrough UCITS ETF - USD +1,91% +0,79%

Samenstelling van de L&G Pharma Breakthrough UCITS ETF - USD

Gewicht
319 USD +0,14%+0,02%+45,08%2.55%
285,8 SEK +0,78%+3,55%+7,04%2.55%
3.235 JPY +0,15%+0,31%+4,69%2.50%
- AUD -.--% - - 2.48%
0,214 EUR -.--% - - 2.48%
- EUR -.--% - - 2.48%
- AUD -.--% - - 2.48%
- USD -.--% - - 2.48%
- RUB - - - 2.48%
21,1 CAD -0,24% - - 2.48%
- CAD -.--% - - 2.48%
- EUR -.--% - - 2.48%
- GBX -.--% - - 2.48%
- NOK -.--% - - 2.48%
0,3938 CAD -17,11% - - 2.48%
171,6 DKK -0,55%+9,33%-3,27%2.41%
231,8 USD -0,02%+2,28%-10,43%2.40%
6.602 JPY -1,17%-0,42%-6,35%2.38%
5.657 JPY +4,24%+1,85%+46,20%2.37%
1.734 DKK -0,60%-3,91%-19,51%2.37%
144,9 USD +1,56%-8,96%-19,67%2.35%
52,02 USD -0,65%-0,08%+40,75%2.34%
48,8 EUR 0,00%-2,59%-0,06%2.33%
106,5 USD -0,24%-3,06%-13,44%2.31%
47,11 USD -1,15%+5,44%-6,88%2.29%
2,1 CHF +3,65%+1,94%-0,66%2.26%
146,4 USD +0,19%-1,80%-6,57%2.23%
19,02 USD +0,48%-5,33%-10,41%2.19%
2.772 JPY -0,02%+0,87%+16,94%2.12%
622 JPY +1,30%+2,64%-46,93%2.12%
5.824 JPY +3,12%+3,37%+9,08%1.89%
6,67 USD +7,93%+6,38%+11,35%1.88%
0,9753 USD -0,90%-4,38%-29,33%1.46%
4479d5a02067bc947c4aa1e2f62db7c._rPo-rGYFRA5IIj8bKhnJvN3wVMfgKTe4cX7qr8_yJM.qIHbvPriW1MAVduwDfIjdpUPuCd6w5SEg6rCnPNTn9ax54mq89VHWnBx0Q

Beschrijving

ISIN-code IE00BF0H7608
Totalekostenratio (TER) 0.49%
Activaklassen Actions
Sector
Grootte
Valuta
Beheerder
Onderliggende waarde Solactive Pharma Breakthrough Value NTR Index - USD

Kenmerken

Dividendbeleid Capitalisation
Methode van replicatie Physique
Rechtsgebied
Replicatiemodel
Aanmaakdatum
23-01-2018
Geografisch zwaartepunt

Distributie

Individuele belegger

Veranderingen in de stand van zaken ( 31-05-2024 )

Volume (EUR) 17 M€
Volume 1 maand 17 M€
AuM 3 months 21 M€
AuM 6 months 28 M€
AuM 12 months 56 M€
  1. Beurs
  2. ETF
  3. Koers BIOT
  4. Samenstelling L&G Pharma Breakthrough UCITS ETF - USD